Saturday 17 October 2026
Export SINT’s income statement to Excel — free account
SINTX TECHNOLOGIES, INC.
SINT Healthcare Medical Devices
SINTX TECHNOLOGIES, INC.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 million, down 64.7% from fiscal 2024. In the quarter to June 2026, revenue grew 199.3%, EPS grew 17.6%, free cash flow fell 38.6% and total debt fell 6.42%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.74
0.03
−1.69%
Follow SINT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
22.08 | 0.00 | 0.00 | 0.00 |
P/S ratio |
9.54 | 10.52 | 9.75 | 6.82 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(4.82) | (4.57) | (4.03) | (3.28) | |
P/B ratio |
2.98 | 3.66 | 11.10 | 1.88 | |
Price to Tangible BV |
3.35 | 4.31 | 21.40 | 2.06 | |
EV/Sales |
4.68 | 6.47 | 8.03 | 4.21 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.81) | (0.77) | (0.85) | (0.55) | |
EV/FCF |
(0.81) | (0.78) | (0.86) | (0.54) | |
Quick Ratio |
1.47 | 1.16 | 0.54 | 1.32 | |
Current Ratio |
1.70 | 1.51 | 1.04 | 2.36 | |
Net Debt/EBITDA |
1.94 | 1.92 | 0.58 | 1.28 | |
Debt/Assets |
0.52% | 0.07% | 1.36% | 0.98% | |
Debt/Equity |
0.01 | 0.00 | 0.12 | 0.02 | |
Asset Turnover |
0.11 | 0.11 | 0.11 | 0.14 | |
Operating CF/Net income |
0.25 | 1.06 | 0.88 | 0.76 | |
Capex/Depreciation |
(0.53) | (0.26) | (0.04) | (0.55) | |
Interest Coverage |
(258.08) | (193.17) | (267.25) | (1,444.00) | |
Research and Development Expense of Revenue |
607.69% | 334.14% | 95.79% | 126.77% | |
Selling, General and Administrative Expense of Revenue |
1,038.94% | 518.28% | 772.11% | 573.23% | |
Intangible Assets out of Total Assets |
0.04 | 0.05 | 0.06 | 0.04 | |
Share Based Compensation of Revenue |
426.92% | 224.48% | 139.47% | 78.10% | |
Graham Net Nets |
0.01 | (0.09) | (0.26) | 0.16 | |
Graham Number |
2.39 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
4.53% | (155.32%) | (216.21%) | (280.50%) | |
Free Cash Flow Yield |
(60.57%) | (79.00%) | (95.59%) | (114.54%) | |
Revenue per Share |
0.07 | 0.10 | 0.09 | 0.09 | |
Operating CF per Share |
(0.85) | (0.85) | (0.62) | (0.57) | |
Capex per Share |
(0.03) | (0.02) | 0.00 | (0.02) | |
Free Cash Flow per Share |
(0.88) | (0.86) | (0.62) | (0.59) | |
Cash per Share |
2.11 | 1.49 | 0.47 | 0.74 | |
Shareholders Equity per Share |
1.37 | 1.06 | 0.23 | 1.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.37 | 1.06 | 0.23 | 1.00 | |
Free Cash Flow |
(2.60) | (2.39) | (2.50) | (2.85) | |
Working Capital |
3.05 | 1.92 | 0.15 | 4.05 | |
Capital Expenditures |
(0.08) | (0.04) | (0.01) | (0.08) | |
Net Current Asset Value |
0.10 | (0.93) | (2.58) | 1.43 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.40 | 0.14 | 0.02 | 0.19 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.23 | 0.19 | 0.23 | 0.21 | |
Average Payables |
0.18 | 0.34 | 0.50 | 0.56 | |
Average Inventory |
0.46 | 0.66 | 0.91 | 1.30 | |
Average Assets |
11.33 | 9.46 | 9.63 | 9.81 | |
Average Common Equity |
4.82 | 3.41 | 3.50 | 4.41 |
Columns are period end dates